CONTACT ENDOSCOPY IN ENT - A Comprehensive 50-Mark Answer

(As per RGUHS Postgraduate ENT Curriculum)

---

INTRODUCTION AND HISTORICAL BACKGROUND

1865 - Desormaux: First described contact endoscopy 
       observing bladder mucosal vascular networks
       
1955 - Jaupitre: Contact cystoscopy + photography/cinematography

1983 - Hamou: Microcolpohysteroscopy in gynaecology 
       (uterine cervix pathology)

1995 - Karl Storz: Developed the contact microlaryngoscope 
       (Model 8715 AA) specifically for ENT use

1995 - Contact microlaryngoscopy first used for laryngeal study

2007 - Combination of contact endoscopy + Narrow Band Imaging 
       (NBI, Olympus) for enhanced vascular visualization

---

PRINCIPLE AND BASIS

1. Microvascular visualization - The contact endoscope is placed directly on mucosa WITHOUT staining; regular light source reveals the subepithelial capillary network
2. Cellular visualization - After staining with methylene blue (4-5 minutes contact), the superficial epithelial cells are identifiable at high magnification

---

EQUIPMENT

Contact Microlaryngoscope (Karl Storz)

• Magnification: 60x and 150x (controlled by a round dial near the proximal ocular end)
• Light source: Standard endoscopy xenon light source; can be upgraded to Olympus NBI system for enhanced vascular contrast
• Recording: Always performed with video recording, preferably in high definition
• Combined with a suspension microlaryngoscope (Kleinsasser type) for intraoperative use

---

TECHNIQUE

FLOWCHART: Contact Endoscopy Procedure

OUTPATIENT (nasal/oropharynx):
Patient seated --> Local anaesthesia spray --> 
Contact endoscope (7215 AA) applied --> 
Vessels visualized (no stain) --> 
Methylene blue applied --> Cells visualized

INTRAOPERATIVE (larynx/hypopharynx):
General anaesthesia + ETT --> 
Suspension microlaryngoscopy --> 
Contact endoscope (8715 AA) introduced --> 
Vessels observed first (no stain) --> 
Methylene blue applied (4-5 min) --> 
60x magnification for cells --> 
150x for detailed nuclear analysis --> 
Video recorded + reviewed with pathologist

Step-by-step operative technique:

1. Patient under general anaesthesia (for larynx/hypopharynx) or topical anaesthesia (nose/oropharynx)
2. Lesion identified under standard microlaryngoscopy
3. Contact endoscope introduced and placed gently against mucosa
4. Vascular pattern examined first - endoscope pressed to mucosa without stain; NBI illumination switches on for deeper vessel visualization
5. Mucosa stained with methylene blue; colouration lasts 4-5 minutes
6. Magnification dial adjusted (60x standard; 150x for detailed nuclear morphology)
7. Endoscope slid over lesion AND surrounding mucosa for mapping
8. All findings video recorded in HD
9. Image reviewed in real time with pathologist/cytologist
10. Biopsy guided by CE findings if required

---

NORMAL HISTOLOGICAL PATTERNS ON CONTACT ENDOSCOPY

A. Normal Squamous Epithelium (Vocal Cord)

• Cells: Polyhedral shape, in continuity with each other
• Nuclei: Round and dark, regular in size
• Cytoplasm: Light blue colouration
• Nucleus:cytoplasm ratio: Regular and homogeneous
• Vessels: Parallel to each other, connected by transverse anastomotic vessels (favouring vibratory function)

B. Normal Ciliated Epithelium

• Nuclei: Round, dark, very close together (high nuclear density)
• Cytoplasm: Limits difficult to define
• Cilia: Filamentous structures visible, especially prominent at nasal/nasopharyngeal mucosa

C. Normal Microvascular Architecture of Upper Aerodigestive Tract

• Most mucosa: Vessels run parallel to the surface connected by anastomoses forming a plexus
• Exception: Perpendicular vessels in gums, hard palate, cheek mucosa, superior tongue surface, nasal papillae
• Vocal cords: Vessels parallel to each other + transverse anastomotic vessels
• Blood flow is pulsatile, visible in real time - red cells moving to the rhythm of heartbeat

---

PATHOLOGICAL PATTERNS

A. Chronic Inflammation

• Nuclei: Enlarged (increased size), increased nucleus:cytoplasm ratio
• General epithelial pattern: Homogeneous but with larger nuclei
• More immature cells at surface (resembling intermediate layers of normal epithelium - due to accelerated cellular turnover)
• Microvascular pattern: Increased vascular density (more vessels + enlargement), but distribution pattern remains organized

B. Fungal Infection

• Small dark dots visible spoiling image = fungal spores
• Hyphae and mycelia identifiable as filamentous structures
• Often associated with chronic inflammatory changes
• In aggressive disease: Profound vascular changes, aberrant vessels, thrombosis, tissue necrosis

C. Keratosis / Leukoplakia

• Isolated cells without nuclei in keratinized areas
• Individual cells cannot be identified in areas of amorphous/laminar structure
• Heterogeneity of cellular population
• Variable degrees of keratinization within same lesion

D. Dysplasia

• Nuclei: Irregular in size and shape
• Nucleus:cytoplasm ratio: Increased
• Population: Heterogeneous, cells from different layers mixed
• Vascular pattern: Disturbed but not yet as severely as carcinoma

E. Carcinoma / Tumour

• Assessment of transition areas
• Identification of early stage disease
• Guidance of biopsy (most abnormal site)
• Guidance of cytology sample collection
• Establishment of safe surgical margins
• Demonstration of skip lesions

F. Papilloma (Recurrent Respiratory Papillomatosis)

• Identification of extent of papilloma
• Mapping of lesion boundaries
• Guidance for surgical excision margins
• Detection of subclinical disease

---

APPLICATIONS IN ENT

Flowchart: Sites of Contact Endoscopy Application

                    CONTACT ENDOSCOPY IN ENT
                           |
        ┌──────────────────┼──────────────────┐
        ↓                  ↓                  ↓
  LARYNX/          NOSE & NASOPHARYNX    ORAL CAVITY &
  HYPOPHARYNX      (7215 AA/BA)          OROPHARYNX
  (8715 AA/BA)     - Chronic rhinitis    (7215 AA/BA)
  - Vocal cord     - Nasal polyps        - Oral mucosa
    lesions        - Nasopharyngeal       lesions
  - Dysplasia        pathology           - Oropharyngeal
  - Carcinoma      - Mucosa mapping       lesions
  - Papilloma
  - Reinke's edema
        |
        ↓
   TRACHEA
   (specialised scope)
   - Subglottic/tracheal lesions

1. Laryngology (Primary Application)

• Evaluation of dysplastic lesions and leukoplakia
• Identification of premalignant changes
• Distinguishing benign from malignant lesions non-invasively
• Intraoperative margin assessment
• Follow-up of treated laryngeal cancers (especially post-irradiation - avoids biopsy complications)
• Assessment of recurrence after treatment

2. Rhinology

• Nasal mucosa vasculature evaluation
• Chronic rhinitis and sinusitis assessment
• Polyp surface characterization
• Nasopharyngeal lesion evaluation

3. Oral Cavity and Pharynx

• Oral precancerous lesion mapping
• Oropharyngeal tumour extent
• Field cancerization assessment across multiple sites
• Pharyngeal lesion characterization

---

ADVANTAGES

1. Non-invasive - no tissue removal required
2. Avoids complications of unnecessary biopsy (especially in irradiated patients)
3. In vivo and in situ cellular visualization - real-time pathological assessment
4. Allows simultaneous evaluation of multiple mucosal sites
5. Facilitates disease mapping - subclinical staging
6. Guides biopsy to most representative site - reduces sampling error
7. Defines safe surgical margins during excision
8. Outpatient-friendly for nasal/oropharyngeal sites
9. Can be combined with NBI for superior vascular analysis
10. Allows interdisciplinary real-time collaboration (surgeon + pathologist)
11. Modifies therapeutic approach in many cases
12. Demonstrates field cancerization - identifies subclinical disease in adjacent areas

---

LIMITATIONS

1. Superficial depth of penetration - cannot assess submucosal invasion
2. Cannot confidently distinguish intraepithelial neoplasia from invasive carcinoma
3. Requires significant experience and training to minimize mucosal trauma
4. Impaired visualization in presence of:
   • Scarring
   • Chronic inflammation
   • Keratosis (amorphous areas are opaque)
5. Cannot replace formal histopathology (not a substitute for biopsy)
6. Limited availability (specialist equipment, Karl Storz)
7. General anaesthesia required for laryngeal/hypopharyngeal examination
8. Learning curve - operator-dependent results
9. Interpretation requires combined surgical + cytopathological expertise

---

COMPARISON WITH HISTOLOGY

---

COMBINED TECHNOLOGIES

Flowchart: Evolution of Contact Endoscopy Technology

Standard white light endoscopy (baseline)
         ↓
Rigid microlaryngoscopy (vessels visible)
         ↓
Contact endoscopy - 60x/150x + methylene blue (cells + vessels)
         ↓
Contact endoscopy + NBI (Olympus 2007) 
   → Enhanced deep vessel visualization
   → Haemoglobin selectively absorbs NBI wavelength
   → Best current method for mucosal microvasculature
         ↓
Contact endoscopy + Autofluorescence
   → Blue/UV light (375-460 nm)
   → Normal mucosa: Green fluorescence
   → Neoplastic mucosa: Reduced autofluorescence, red-violet
   → Sensitivity 87-97%, Specificity 78-87%
         ↓
FUTURE: AI-assisted pattern recognition + confocal endoscopy

Narrow Band Imaging (NBI) + Contact Endoscopy

• NBI light selectively absorbed by haemoglobin in erythrocytes
• Dramatically improves contrast of vessels relative to background mucosa
• Visualizes deeper vessels not seen with standard light
• Intraepithelial papillary capillary loops (IPCL) - hallmark of premalignant/malignant change
• Currently the most detailed clinical method for studying upper aerodigestive tract microvasculature

Autofluorescence

• Fluorophores (collagen, elastin, mitochondria, porphyrins) emit light at specific wavelengths
• Normal mucosa: Green fluorescence
• Neoplastic mucosa: Reduced autofluorescence - red-violet colour
• Sensitivity 87-97%, Specificity 78-87% for invasive carcinoma
• Limitations: Low specificity (false positives from granulation tissue, scarring, chronic inflammation); restricted depth of penetration

---

DIAGNOSTIC ALGORITHM

PATIENT WITH LARYNGEAL/MUCOSAL LESION
              ↓
    Flexible laryngoscopy (outpatient)
              ↓
    Lesion identified
              ↓
    ┌─────────────────────────┐
    | Microlaryngoscopy under |
    | general anaesthesia     |
    └─────────────────────────┘
              ↓
    Contact endoscopy performed
    (Step 1: Vessels without stain)
    (Step 2: Methylene blue → Cells)
              ↓
    ┌──────────────────────────────────────────┐
    |  CE Pattern Analysis                      |
    |                                           |
    | Normal → No further action                |
    |                                           |
    | Inflammation/Fungal → Medical treatment   |
    |                                           |
    | Keratosis/Dysplasia → Targeted biopsy     |
    |   + map lesion extent                     |
    |   + define resection margins              |
    |                                           |
    | Carcinoma pattern → Formal biopsy         |
    |   + NBI pattern (IPCL)                   |
    |   + staging endoscopy                    |
    |   + surgical planning                    |
    └──────────────────────────────────────────┘
              ↓
    Histopathology (confirms CE findings)
              ↓
    Treatment (with CE-guided margins)

---

RECENT ADVANCES

1. NBI-assisted contact endoscopy (2007-present): The combination of CE + Olympus NBI is currently the gold standard for in vivo mucosal microvasculature analysis. IPCL patterns (Types I-V, Ni classification) guide risk stratification.
2. Confocal laser endomicroscopy (CLE): An emerging technique using 488 nm laser providing cellular resolution to 250 microns depth - complementary to CE. Studies in head and neck cancer are ongoing.
3. Optical coherence tomography (OCT): Provides cross-sectional subsurface imaging to 2 mm depth - overcomes the depth limitation of CE.
4. High-definition contact endoscopy: HD video recording allows superior image capture and telemedicine consultation.
5. AI-assisted analysis: Machine learning algorithms are being developed for automated pattern recognition of CE images, particularly for dysplasia grading.
6. Contact endoscopy in transoral robotic surgery (TORS): Integration of CE during robotic surgery for real-time margin assessment.
7. Fluorescence-guided surgery: Integration of photodynamic techniques with CE principles for enhanced tumour detection.
8. 5-aminolevulinic acid (5-ALA) fluorescence: Tumour-specific fluorophore used as adjunct for CE-based tumour mapping.

---

KEY POINTS (for exam)

1. CE allows non-invasive evaluation of microvasculature AND cells simultaneously
2. CE allows appreciation of cellular differences at transition zones (squamous-to-ciliated)
3. Most upper aerodigestive mucosa has vessels running parallel to the surface
4. CE may assist identification of safe surgical margins
5. Sensitivity 90%, Specificity 94%, Concordance with histology 88%
6. NOT a substitute for histology - a complementary research and clinical tool
7. Most useful in irradiated patients where biopsy carries higher risk
8. The contact microlaryngoscope was developed in 1995 by Karl Storz
9. Methylene blue staining lasts 4-5 minutes
10. Magnifications available: 60x and 150x

---

REFERENCES FROM STANDARD TEXTBOOKS

---

SUMMARY MIND MAP

              CONTACT ENDOSCOPY IN ENT
                        |
    ┌──────────┬─────────┼──────────┬──────────┐
    ↓          ↓         ↓          ↓          ↓
HISTORY    EQUIPMENT  TECHNIQUE  FINDINGS   ADVANCES
(1865→     Karl Storz (GA/LA→    Normal     NBI+CE
1995)      8715AA     Methylene  Inflamm    Confocal
           60x/150x   Blue→      Dysplasia  OCT
           5.8mm      Vessels→   Ca         AI
                      Cells)     Papilloma  5-ALA
    |
    ↓
ADVANTAGES vs LIMITATIONS
Non-invasive / Superficial only
Intraoperative / GA needed
Irradiated field / Cannot confirm invasion
Margin mapping / Keratosis obscures
Outpatient (nose) / Learning curve

---

EXAMINER'S CHECKLIST (RGUHS 50-mark format)

• Definition and principle (5 marks)
• History and development (5 marks)
• Equipment and models (5 marks)
• Technique - outpatient and intraoperative (10 marks)
• Normal patterns - squamous, ciliated, vascular (5 marks)
• Pathological patterns - inflammation, keratosis, dysplasia, carcinoma (10 marks)
• Advantages and limitations (5 marks)
• Comparison with histology (sensitivity/specificity) (3 marks)
• Advanced imaging combinations (NBI, autofluorescence) (4 marks)
• Recent advances (3 marks)

---

• Scott-Brown's Otorhinolaryngology Head & Neck Surgery, 8th Ed, Vol 1 - Chapter 51 (M. Andrea & O. Dias - dedicated chapter on Contact Endoscopy)
• Scott-Brown's Otorhinolaryngology Head & Neck Surgery, 8th Ed, Vol 2 - Chapter 61 (Contact endoscopy and microlaryngoscopy)
• Andrea M, Dias O, Macor C - Contact endoscopy of the nasal mucosa. Acta Otolaryngol 1997This is a complete, exam-ready 50-mark answer on Contact Endoscopy in ENT. Here is a summary of what's covered:

---

What This Answer Covers (RGUHS 50-mark Structure)